Search: onr:"swepub:oai:DiVA.org:su-180352" > The global, regiona...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 14044naa a2202689 4500 | |
001 | oai:DiVA.org:su-180352 | |
003 | SwePub | |
008 | 200406s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-1803522 URI |
024 | 7 | a https://doi.org/10.1016/S2468-1253(19)30349-82 DOI |
040 | a (SwePub)su | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Sepanlou, Sadaf G.4 aut |
245 | 1 0 | a The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017 :b a systematic analysis for the Global Burden of Disease Study 2017 |
264 | 1 | c 2020 |
338 | a print2 rdacarrier | |
520 | a Background Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in this paper) are a major cause of morbidity and mortality globally, although the burden and underlying causes differ across locations and demographic groups. We report on results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 on the burden of cirrhosis and its trends since 1990, by cause, sex, and age, for 195 countries and territories. Methods We used data from vital registrations, vital registration samples, and verbal autopsies to estimate mortality. We modelled prevalence of total, compensated, and decompensated cirrhosis on the basis of hospital and claims data. Disability-adjusted life-years (DALYs) were calculated as the sum of years of life lost due to premature death and years lived with disability. Estimates are presented as numbers and age-standardised or age-specific rates per 100 000 population, with 95% uncertainty intervals (UIs). All estimates are presented for five causes of cirrhosis: hepatitis B, hepatitis C, alcohol-related liver disease, non-alcoholic steatohepatitis (NASH), and other causes. We compared mortality, prevalence, and DALY estimates with those expected according to the Socio-demographic Index (SDI) as a proxy for the development status of regions and countries. Findings In 2017, cirrhosis caused more than 1.32 million (95% UI 1.27-1.45) deaths (440000 [416 000-518 000; 33.3%] in females and 883 000 [838 000-967 000; 66.7%] in males) globally, compared with less than 899 000 (829 000-948 000) deaths in 1990. Deaths due to cirrhosis constituted 2.4% (2.3-2.6) of total deaths globally in 2017 compared with 1.9% (1.8-2.0) in 1990. Despite an increase in the number of deaths, the age-standardised death rate decreased from 21.0 (19.2-22.3) per 100 000 population in 1990 to 16.5 (15.8-18-1) per 100 000 population in 2017. Sub-Saharan Africa had the highest age-standardised death rate among GBD super-regions for all years of the study period (32.2 [25.8-38.6] deaths per 100 000 population in 2017), and the high-income super-region had the lowest (10.1 [9.8-10-5] deaths per 100 000 population in 2017). The age-standardised death rate decreased or remained constant from 1990 to 2017 in all GBD regions except eastern Europe and central Asia, where the age-standardised death rate increased, primarily due to increases in alcohol-related liver disease prevalence. At the national level, the age-standardised death rate of cirrhosis was lowest in Singapore in 2017 (3.7 [3.3-4.0] per 100 000 in 2017) and highest in Egypt in all years since 1990 (103.3 [64.4-133.4] per 100 000 in 2017). There were 10.6 million (10.3-10.9) prevalent cases of decompensated cirrhosis and 112 million (107-119) prevalent cases of compensated cirrhosis globally in 2017. There was a significant increase in age-standardised prevalence rate of decompensated cirrhosis between 1990 and 2017. Cirrhosis caused by NASH had a steady age-standardised death rate throughout the study period, whereas the other four causes showed declines in age-standardised death rate. The age-standardised prevalence of compensated and decompensated cirrhosis due to NASH increased more than for any other cause of cirrhosis (by 33.2% for compensated cirrhosis and 54.8% for decompensated cirrhosis) over the study period. From 1990 to 2017, the number of prevalent cases snore than doubled for compensated cirrhosis due to NASH and more than tripled for decompensated cirrhosis due to NASH. In 2017, age-standardised death and DALY rates were lower among countries and territories with higher SDI. Interpretation Cirrhosis imposes a substantial health burden on many countries and this burden has increased at the global level since 1990, partly due to population growth and ageing. Although the age-standardised death and DALY rates of cirrhosis decreased from 1990 to 2017, numbers of deaths and DALYs and the proportion of all global deaths due to cirrhosis increased. Despite the availability of effective interventions for the prevention and treatment of hepatitis B and C, they were still the main causes of cirrhosis burden worldwide, particularly in low-income countries. The impact of hepatitis B and C is expected to be attenuated and overtaken by that of NASH in the near future. Cost-effective interventions are required to continue the prevention and treatment of viral hepatitis, and to achieve early diagnosis and prevention of cirrhosis due to alcohol-related liver disease and NASH. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
700 | 1 | a Safiri, Saeid4 aut |
700 | 1 | a Bisignano, Catherine4 aut |
700 | 1 | a Ikuta, Kevin S.4 aut |
700 | 1 | a Merat, Shahin4 aut |
700 | 1 | a Saberifiroozi, Mehdi4 aut |
700 | 1 | a Poustchi, Hossein4 aut |
700 | 1 | a Tsoi, Derrick4 aut |
700 | 1 | a Colombara, Danny V.4 aut |
700 | 1 | a Abdoli, Amir4 aut |
700 | 1 | a Adedoyin, Rufus Adesoji4 aut |
700 | 1 | a Afarideh, Mohsen4 aut |
700 | 1 | a Agrawal, Sutapa4 aut |
700 | 1 | a Ahmad, Sohail4 aut |
700 | 1 | a Ahmadian, Elham4 aut |
700 | 1 | a Ahmadpour, Ehsan4 aut |
700 | 1 | a Akinyemiju, Tomi4 aut |
700 | 1 | a Akunna, Chisom Joyqueenet4 aut |
700 | 1 | a Alipour, Vahid4 aut |
700 | 1 | a Almasi-Hashiani, Amir4 aut |
700 | 1 | a Almulhim, Abdulaziz M.4 aut |
700 | 1 | a Al-Raddadi, Rajaa M.4 aut |
700 | 1 | a Alvis-Guzman, Nelson4 aut |
700 | 1 | a Anber, Nahla Hamed4 aut |
700 | 1 | a Angus, Colin4 aut |
700 | 1 | a Anoushiravani, Amir4 aut |
700 | 1 | a Arabloo, Jalal4 aut |
700 | 1 | a Araya, Ephrem Mebrahtu4 aut |
700 | 1 | a Asmelash, Daniel4 aut |
700 | 1 | a Ataeinia, Bahar4 aut |
700 | 1 | a Ataro, Zerihun4 aut |
700 | 1 | a Atout, Maha Moh'd Wahbi4 aut |
700 | 1 | a Ausloos, Floriane4 aut |
700 | 1 | a Awasthi, Ashish4 aut |
700 | 1 | a Badawi, Alaa4 aut |
700 | 1 | a Banach, Maciej4 aut |
700 | 1 | a Bejarano Ramirez, Diana Fernanda4 aut |
700 | 1 | a Bhagavathula, Akshaya Srikanth4 aut |
700 | 1 | a Bhala, Neeraj4 aut |
700 | 1 | a Bhattacharyya, Krittika4 aut |
700 | 1 | a Biondi, Antonio4 aut |
700 | 1 | a Bolla, Srinivasa Rao4 aut |
700 | 1 | a Boloor, Archith4 aut |
700 | 1 | a Borzi, Antonio M.4 aut |
700 | 1 | a Butt, Zahid A.4 aut |
700 | 1 | a Alberto Camera, Luis L. A.4 aut |
700 | 1 | a Campos-Nonato, Ismael R.4 aut |
700 | 1 | a Carvalho, Felix4 aut |
700 | 1 | a Dinh-Toi, Chu4 aut |
700 | 1 | a Chung, Sheng-Chia4 aut |
700 | 1 | a Cortesi, Paolo Angelo4 aut |
700 | 1 | a Costa, Vera M.4 aut |
700 | 1 | a Cowie, Benjamin C.4 aut |
700 | 1 | a Daryani, Ahmad4 aut |
700 | 1 | a de Courten, Barbora4 aut |
700 | 1 | a Demoz, Gebre Teklemariam4 aut |
700 | 1 | a Desai, Rupak4 aut |
700 | 1 | a Dharmaratne, Samath Dhamminda4 aut |
700 | 1 | a Djalalinia, Shirin4 aut |
700 | 1 | a Hoa, Thi4 aut |
700 | 1 | a Dorostkar, Fariba4 aut |
700 | 1 | a Drake, Thomas M.4 aut |
700 | 1 | a Dubey, Manisha4 aut |
700 | 1 | a Duncan, Bruce B.4 aut |
700 | 1 | a Effiong, Andem4 aut |
700 | 1 | a Eftekhari, Aziz4 aut |
700 | 1 | a Elsharkawy, Aisha4 aut |
700 | 1 | a Etemadi, Arash4 aut |
700 | 1 | a Farahmand, Mohammad4 aut |
700 | 1 | a Farzadfar, Farshad4 aut |
700 | 1 | a Fernandes, Eduarda4 aut |
700 | 1 | a Filip, Irina4 aut |
700 | 1 | a Fischer, Florian4 aut |
700 | 1 | a Gebremedhin, Ketema Bizuwork Bizuwork4 aut |
700 | 1 | a Geta, Birhanu4 aut |
700 | 1 | a Gilani, Syed Amir4 aut |
700 | 1 | a Gill, Paramjit Singh4 aut |
700 | 1 | a Alma Gutierrez, Reyna4 aut |
700 | 1 | a Haile, Michael Tamene4 aut |
700 | 1 | a Haj-Mirzaian, Arvin4 aut |
700 | 1 | a Hamid, Saeed S.4 aut |
700 | 1 | a Hasankhani, Milad4 aut |
700 | 1 | a Hasanzadeh, Amir4 aut |
700 | 1 | a Hashemian, Maryam4 aut |
700 | 1 | a Hassen, Hamid Yimam4 aut |
700 | 1 | a Hay, Simon I.4 aut |
700 | 1 | a Hayat, Khezar4 aut |
700 | 1 | a Heidari, Behnam4 aut |
700 | 1 | a Henok, Andualem4 aut |
700 | 1 | a Chi, Linh4 aut |
700 | 1 | a Hostiuc, Mihaela4 aut |
700 | 1 | a Hostiuc, Sorin4 aut |
700 | 1 | a Hsieh, Vivian Chia-rong4 aut |
700 | 1 | a Igumbor, Ehimario U.4 aut |
700 | 1 | a Ilesanmi, Olayinka Stephen4 aut |
700 | 1 | a Irvani, Seyed Sina Naghibi4 aut |
700 | 1 | a Balalami, Nader Jafari4 aut |
700 | 1 | a James, Spencer L.4 aut |
700 | 1 | a Jeemon, Panniyammakal4 aut |
700 | 1 | a Jha, Ravi Prakash4 aut |
700 | 1 | a Jonas, Jost B.4 aut |
700 | 1 | a Jozwiak, Jacek Jerzy4 aut |
700 | 1 | a Kabir, Ali4 aut |
700 | 1 | a Kasaeian, Amir4 aut |
700 | 1 | a Kassaye, Hagazi Gebremedhin4 aut |
700 | 1 | a Kefale, Adane Teshome4 aut |
700 | 1 | a Khan, Rovshan Khalilov Muhammad Ali4 aut |
700 | 1 | a Khan, Ejaz Ahmad4 aut |
700 | 1 | a Khater, Amir4 aut |
700 | 1 | a Kim, Yun Jin4 aut |
700 | 1 | a Koyanagi, Ai4 aut |
700 | 1 | a La Vecchia, Carlo4 aut |
700 | 1 | a Lim, Lee-Ling4 aut |
700 | 1 | a Lopez, Alan D.4 aut |
700 | 1 | a Lorkowski, Stefan4 aut |
700 | 1 | a Lotufo, Paulo A.4 aut |
700 | 1 | a Lozano, Rafael4 aut |
700 | 1 | a Abd El Razek, Muhammed Magdy4 aut |
700 | 1 | a Hue, Thi4 aut |
700 | 1 | a Manafi, Navid4 aut |
700 | 1 | a Manafi, Amir4 aut |
700 | 1 | a Mansournia, Mohammad Ali4 aut |
700 | 1 | a Mantovani, Lorenzo Giovanni4 aut |
700 | 1 | a Mazzaglia, Giampiero4 aut |
700 | 1 | a Mehta, Dhruv4 aut |
700 | 1 | a Mendoza, Walter4 aut |
700 | 1 | a Menezes, Ritesh G.4 aut |
700 | 1 | a Mengesha, Melkamu Merid4 aut |
700 | 1 | a Meretoja, Tuomo J.4 aut |
700 | 1 | a Mestrovic, Tomislav4 aut |
700 | 1 | a Miazgowski, Bartosz4 aut |
700 | 1 | a Miller, Ted R.4 aut |
700 | 1 | a Mirrakhimov, Erkin M.4 aut |
700 | 1 | a Mithra, Prasanna4 aut |
700 | 1 | a Moazen, Babak4 aut |
700 | 1 | a Moghadaszadeh, Masoud4 aut |
700 | 1 | a Mohammadian-Hafshejani, Abdollah4 aut |
700 | 1 | a Mohammed, Shafiu4 aut |
700 | 1 | a Mokdad, Ali H.4 aut |
700 | 1 | a Montero-Zamora, Pablo A.4 aut |
700 | 1 | a Moradi, Ghobad4 aut |
700 | 1 | a Naimzada, Mukhammad David4 aut |
700 | 1 | a Nayak, Vinod4 aut |
700 | 1 | a Negoi, Ionut4 aut |
700 | 1 | a Trang, Huyen4 aut |
700 | 1 | a Ofori-Asenso, Richard4 aut |
700 | 1 | a Oh, In-Hwan4 aut |
700 | 1 | a Olagunju, Tinuke O.4 aut |
700 | 1 | a Padubidri, Jagadish Rao4 aut |
700 | 1 | a Pakshir, Keyvan4 aut |
700 | 1 | a Pana, Adrian4 aut |
700 | 1 | a Pathak, Mona4 aut |
700 | 1 | a Pourshams, Akram4 aut |
700 | 1 | a Rabiee, Navid4 aut |
700 | 1 | a Radfar, Amir4 aut |
700 | 1 | a Rafiei, Alireza4 aut |
700 | 1 | a Ramezanzadeh, Kiana4 aut |
700 | 1 | a Rana, Saleem Muhammad M.4 aut |
700 | 1 | a Rawaf, Salman4 aut |
700 | 1 | a Rawaf, David Laith4 aut |
700 | 1 | a Reiner, Robert C.4 aut |
700 | 1 | a Roever, Leonardo4 aut |
700 | 1 | a Room, Robinu Stockholms universitet,Centrum för socialvetenskaplig alkohol- och drogforskning (SoRAD),La Trobe University, Australia4 aut0 (Swepub:su)room |
700 | 1 | a Roshandel, Gholamreza4 aut |
700 | 1 | a Safari, Saeed4 aut |
700 | 1 | a Samy, Abdallah M.4 aut |
700 | 1 | a Sanabria, Juan4 aut |
700 | 1 | a Sartorius, Benn4 aut |
700 | 1 | a Schmidt, Maria Ines4 aut |
700 | 1 | a Senthilkumaran, Subramanian4 aut |
700 | 1 | a Shaikh, Masood Ali4 aut |
700 | 1 | a Sharif, Mehdi4 aut |
700 | 1 | a Sharifi, Amrollah4 aut |
700 | 1 | a Shigematsu, Mika4 aut |
700 | 1 | a Singh, Jasvinder A.4 aut |
700 | 1 | a Soheili, Amin4 aut |
700 | 1 | a Suleria, Hafiz Ansar Rasul4 aut |
700 | 1 | a Teklehaimanot, Berhane Fseha4 aut |
700 | 1 | a Tesfay, Berhe Etsay4 aut |
700 | 1 | a Vacante, Marco4 aut |
700 | 1 | a Vahedian-Azimi, Amir4 aut |
700 | 1 | a Valdez, Pascual R.4 aut |
700 | 1 | a Vasankari, Tommi Juhani4 aut |
700 | 1 | a Giang, Thu4 aut |
700 | 1 | a Waheed, Yasir4 aut |
700 | 1 | a Weldegwergs, Kidu Gidey4 aut |
700 | 1 | a Werdecker, Andrea4 aut |
700 | 1 | a Westerman, Ronny4 aut |
700 | 1 | a Wondafrash, Dawit Zewdu4 aut |
700 | 1 | a Wondmieneh, Adam Belay4 aut |
700 | 1 | a Yeshitila, Yordanos Gizachew4 aut |
700 | 1 | a Yonemoto, Naohiro4 aut |
700 | 1 | a Yu, Chuanhua4 aut |
700 | 1 | a Zaidi, Zoubida4 aut |
700 | 1 | a Zarghi, Afshin4 aut |
700 | 1 | a Zelber-Sagi, Shira4 aut |
700 | 1 | a Zewdie, Kaleab Alemayehu4 aut |
700 | 1 | a Zhang, Zhi-Jiang4 aut |
700 | 1 | a Zhao, Xiu-Ju4 aut |
700 | 1 | a Naghavi, Mohsen4 aut |
700 | 1 | a Malekzadeh, Reza4 aut |
710 | 2 | a Stockholms universitetb Centrum för socialvetenskaplig alkohol- och drogforskning (SoRAD)4 org |
773 | 0 | t The Lancet Gastroenterology & Hepatologyg 5:3, s. 245-266q 5:3<245-266x 2468-1253 |
856 | 4 | u https://doi.org/10.1016/S2468-1253(19)30349-8y Fulltext |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-180352 |
856 | 4 8 | u https://doi.org/10.1016/S2468-1253(19)30349-8 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.